Jim Cramer, host of the television investment show “Mad Money,” issued “Buy” recommendations on these stocks on Aug. 3. I take a look at them today to see how they are performing.

Allergan Inc. (AGN) – Founded in 1948, AGN develops and markets specialty pharmaceuticals and devices for a variety of medical specialty markets. Its market capitalization is $25.79 billion. It is currently trading around $84.55. It opened at $78.87 the morning after Cramer’s “Buy” recommendation, which was down from $79.79 the previous day. On Aug. 10, it reached a low of $70.36, and on Sept. 20 it reached a high of $84.30. Over the past 52 weeks it has fluctuation between a low of $64.95 and a high of $85.74. Its dividend yield is 0.2 percent, or $0.20 a share. It is showing a loss per share of $0.01. Price/earnings to growth is 1.53, and price to book value is 5.11. Return on equity is only 0.04 percent. Quarterly revenue growth is 13.6 percent, and quarterly earnings growth is 2.7 percent. AGN reports $2.61 billion in cash on hand and debt of $1.59 billion.

AGN’s mega-cap competitor Johnson& Johnson (JNJ) is a 2011 Dividend Champion, having increased its payout 49 years in a row. Its dividend yield is 3.7 percent or $2.28. Earnings per share is 44.18, and price to earnings ratio is 15.27. Price/earnings to growth is 2.23, and price to book value is 2.77. Return on equity is 20.20 percent. Quarterly revenue growth is 8.3 percent. JNJ is showing a decline in quarterly earnings of 1.5 percent. To continue reading, click here.